Markus Wartmann
Novartis (China)(CN)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Synthetic Organic Chemistry Methods, Fibroblast Growth Factor Research, Kruppel-like factors research, Epigenetics and DNA Methylation
Most-Cited Works
- → cPLA2 is phosphorylated and activated by MAP kinase(1993)1,872 cited
- → Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase(2011)487 cited
- → CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors(2014)432 cited
- → Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1(1994)331 cited
- → AEE788(2004)317 cited
- → The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex.(1994)264 cited